Moxalactam is not more active on extended spectrum β-lactamase (ESBL) producing bacteria than on non-ESBL producers

Moxalactam is not more active on extended spectrum β-lactamase (ESBL) producing bacteria than on non-ESBL producers

Bhoj R Singh Division of Epidemiology, ICAR-Indian Veterinary Research Institute, Izatnagar, IndiaIn a recently published article1 moxalactam has been claimed to be very effective on extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae, concluding “MO...

Full description

Bibliographic Details
Main Author: Singh BR
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:Infection and Drug Resistance
Subjects:
Moxalactam
Latamox
Carbapenem
MBL
ESBL
Online Access:https://www.dovepress.com/moxalactam-is-not-more-active-on-extended-spectrum-beta-lactamase-esbl-peer-reviewed-article-IDR

Internet

https://www.dovepress.com/moxalactam-is-not-more-active-on-extended-spectrum-beta-lactamase-esbl-peer-reviewed-article-IDR

Similar Items